Skip to content

Clinical trials

Bile Duct Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bile Duct Neoplasms Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20192
20202
20222
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ASLAN Pharmaceuticals1
Actym Therapeutics, Inc.1
AstraZeneca1
BioNTech SE1
DualityBio Inc.1
Elevation Oncology1
Forma Therapeutics, Inc.1
Full-Life Technologies UK Limited1
Imugene Limited1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bile Duct Neoplasms13
Cholangiocarcinoma9
Colorectal Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Endometrial Neoplasms4
Esophageal Neoplasms4
Gallbladder Neoplasms4
Ovarian Neoplasms4
Pancreatic Neoplasms4
Stomach Neoplasms4

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.